is semaglutide under patent The upcoming expiry of the in India in mid-March 2026 expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Semaglutide Composition-of-Matter Patent Lifecycle |

Thibault, thanks so much for taking the time to talk

At some point we will see that plateau as more consumers try it. At Medica, every client employer group covers GLP-1 medications for FDA-approved diabetes indications

Losing a significant amount of weight alters how the body distributes pressure across the spine

The initial rush also led to overstocking of the drugs, with the market reporting excess inventory of nearly 100 crore by June

Blood sugar improvements, blood pressure reductions, and lipid changes tend to reverse once the medication is discontinued

After a few weeks of consistent use, I noticed I felt more balanced throughout the day and didnt experience the same energy crashes I used to